Adjuvant Alectinib Could Aid Disease-Free Survival in ALK-Positive NSCLC
A 76% lower risk was displayed with adjuvant alectinib compared to chemotherapy treatment for non–small cell lung cancer.
Source: pharmacytimes.com
Roche Alectinib News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Roche Alectinib. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Roche Alectinib Today - Breaking & Trending Today